Bad Blood (e-bog) af Carreyrou, John
Carreyrou, John (forfatter)

Bad Blood e-bog

99,54 DKK (inkl. moms 124,42 DKK)
Now with a new afterword covering the months-long landmark trials of Theranos founders Elizabeth Holmes and Sunny Balwani.'I couldn't put down this thriller' - Bill GatesWinner of the Financial Times/McKinsey Business Book of the Year Award.The shocking true story of the breathtaking rise and collapse of Theranos, the multibillion-dollar biotech startup founded by Elizabeth Holmes, written by t...
E-bog 99,54 DKK
Forfattere Carreyrou, John (forfatter)
Forlag Picador
Udgivet 30 marts 2023
Længde 400 sider
Genrer 1KBB-US-WPCF
Sprog English
Format epub
Beskyttelse LCP
ISBN 9781035028627
Now with a new afterword covering the months-long landmark trials of Theranos founders Elizabeth Holmes and Sunny Balwani.'I couldn't put down this thriller' - Bill GatesWinner of the Financial Times/McKinsey Business Book of the Year Award.The shocking true story of the breathtaking rise and collapse of Theranos, the multibillion-dollar biotech startup founded by Elizabeth Holmes, written by the prize-winning journalist who first broke the story and pursued it to the end.Seen as the female Steve Jobs, Theranos founder and CEO Elizabeth Holmes was a brilliant Stanford dropout whose startup 'unicorn' promised to revolutionize the medical industry with a machine that would make blood testing significantly faster and easier. Backed by wealthy investors, Theranos sold shares that valued the company at more than $9 billion.There was just one problem: the technology didn't work . . .Despite threats of legal action, brave whistleblowers started to talk. They revealed a culture of intimidation and secrecy, technology that repeatedly failed, results sent to real patients that were incorrect but upon which life-changing medical decisions were being made, with devastating consequences.The riveting story behind The Dropout, in Bad Blood, John Carreyrou investigates the biggest corporate fraud since Enron, a tale of ambition and scandal set amid the bold promises of Silicon Valley.'A tale of corporate fraud and legal browbeating that reads like a crime thriller' - The 10 Best Nonfiction Books, TIME